Oxitec, GBIT launch Friendly Aedes mosquito 0utdoor caged trials in Dawalwadi

2017-01-27 10:46:19

Outdoor caged trials of Oxitec’s Friendly Aedes mosquito have been initiated to demonstrate the efficacy of the Friendly mosquitoes in suppressing the local Aedes aegypti population.By Team ABLEThe Gangabishan Bhikulal Investment and Trading Limited (GBIT) and Oxitec have co-launched the Friendly Aedes project in Dawalwadi, India. Outdoor caged trials of Oxitec’s Friendly Aedes mosquito have b

Read more

Globavir’s PanGlob Dengue rRT-PCR kit receives approval for sales and distribution in India

2017-01-27 10:42:48

Globavir Biosciences has received approval of its PanGlob Dengue rRT-PCR kit from the Ministry of Health & Family Welfare in India.By Team ABLEGlobavir Biosciences, a California-based biotechnology company developing dengue diagnostics and small molecule drugs to treat cancer and infectious diseases, has received approval of its PanGlob Dengue rRT-PCR kit from the Ministry of Health & Fami

Read more

GST on healthcare will make medicare unaffordable: ASSOCHAM-TechSci study

2017-01-27 10:40:48

The paper cautioned that if GST is levied on healthcare services and facilities, the much-avowed national goal to provide universal healthcare coverage would take a hit.By Team ABLE“The healthcare sector catering to the unmet health needs of the society should be kept out of the purview of the Goods and Services Tax (GST) or else medical care would become expensive and unaffordable for the commo

Read more

Ministry of Health, Malaysia awards Biocon three-year contract for supplying recombinant human insulin formulations

2017-01-25 16:00:32

Biocon will supply rh-insulin manufactured at its new facility in Malaysia to public sector hospitals and clinics through CCM Pharmaceuticals.By Team ABLEAsia\'s premier biopharmaceuticals company Biocon has announced that the Ministry of Health (MoH), Malaysia, has awarded a three-year contract, to its subsidiary, Biocon SDN BHD in Malaysia, for supplying recombinant human insulin (rh-insulin) fo

Read more

Biocon posts robust Q3 FY17 financial results; company’s net profit up 65% at Rs 171 crore

2017-01-25 15:56:12

Biocon has announced its consolidated financial results for the third quarter ended on December 31, 2016. By Team ABLEBiocon reported a revenue growth of 32 percent at Rs 1,092 crore in Q3 FY17, which was led by a robust growth of 61 percent in the biologics business, 24 percent growth recorded by small molecules, 18 percent by branded formulations and 17 percent growth by research services busine

Read more

MTal stresses on the need to incentivize investment for MedTech manufacturing to accelerate Make in India

2017-01-25 15:50:26

Pavan Choudary, Director General, Medical Technology Association of India (MTaI), urged for an urgent review of import duties on medical devices.By Team ABLEWith the Union Budget 2017 around the corner, the Medical Technology Association of India (MTaI) has stressed on certain expectations from on import duties. According to MTaI, the import duties on medical devices and equipments have already be

Read more

The Cancer Genome Atlas investigators unravel genomic features of cervical cancer

2017-01-24 10:00:40

Investigators with The Cancer Genome Atlas (TCGA) Research Network have identified novel genomic and molecular characteristics of cervical cancer that can possibly aid in the sub-classification of the disease.By Team ABLEA new study, an analysis of the genomes of 178 primary cervical cancers, found that over 70 percent of the tumors had genomic alterations in either one or both of two important ce

Read more

GeoVax initiates HIV human clinical trial

2017-01-24 09:59:09

The phase 1 trial is being conducted by\n the HIV Vaccine Trials Network and is funded by the National Institute \nof Allergy and Infectious Diseases, part of the National Institutes of \nHealth.By Team ABLEGeoVax Labs, a \nbiotechnology company developing human vaccines, has announced that the \ncompany has initiated the next human clinical trial of its preventive \nHIV vaccine, GOVX-B11. The pha

Read more

Health Ministry to launch population-based prevention, screening and control program for five non-communicable diseases

2017-01-23 10:00:02

The Ministry of Health and Family Welfare will launch a population-based prevention, screening and control program for five common non-communicable diseases, namely Hypertension, Diabetes, and Cancers of oral cavity, breast and cervix.By Team ABLEAs part of the National Health Mission, the Ministry of Health and Family Welfare (MoHFW) will launch a population-based prevention, screening and contro

Read more

Tata Memorial Centre organizes two-day conference on Healthcare: A Commodity or Basic Human Need?

2017-01-23 09:58:19

The goal of this interaction would be to evolve a healthcare model that is not only ideal for the developing countries but is also use worthy in the developed world by providing cost effective solutions.By Team ABLEThe Tata Memorial Centre at Mumbai is in the midst of its 75th year of its existence. A series of meetings and conferences have been planned to commemorate the platinum jubilee year. Th

Read more